![Tae-Goo Kim](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tae-Goo Kim
Director Ejecutivo en DSK CO., LTD. .
Fortuna: 10 M $ al 31/05/2024
Origen de la red de primer grado Tae-Goo Kim.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Public Company | Computer Peripherals | 9 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Tae-Goo Kim a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
HYUNDAI SECURITIES CO LTD | Investment Managers | Director/Board Member | |
Yonsei University | College/University | Graduate Degree Graduate Degree | |
Konkuk University | College/University | Doctorate Degree Undergraduate Degree | |
KODI CO., LTD | Household/Personal Care | Chief Executive Officer Comptroller/Controller/Auditor | |
Myongji University | College/University | Undergraduate Degree | |
Medica Korea Co. Ltd.
![]() Medica Korea Co. Ltd. Pharmaceuticals: MajorHealth Technology Medica Korea Co. Ltd. engages in the research, development, manufacture, sale and export of medicines and pharmaceuticals. It distributes medicine to wholesalers, clinics and hospitals through sales channels. The firm exports its pharmaceutial products to the countries such as Singapore, Hong Kong, Vietnam and Chile. The company was founded in 1976 and is headquartered in Seoul, South Korea. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
UNECO CO.,LTD. | Industrial Machinery | Chief Executive Officer | |
Synergy Partners Co., Ltd.
![]() Synergy Partners Co., Ltd. Financial ConglomeratesFinance Synergy Partners Co., Ltd. engages in the provision of investment consulting services. The company was founded on July 2, 2010 and is headquartered in Busan, South Korea. | Financial Conglomerates | President | |
Premierbio Co., Ltd.
![]() Premierbio Co., Ltd. Pharmaceuticals: OtherHealth Technology Premierbio Co., Ltd. is engaged in developing Protoxin. It offers development and supply of Botulinum type A Toxin. The company was founded on September 25, 2015 and is headquartered in Anseong, South Korea. | Pharmaceuticals: Other | Chief Executive Officer | |
Busan National University of Education | College/University | Undergraduate Degree |
Estadísticas
Internacional
Corea del Sur | 11 |
Sectorial
Consumer Services | 5 |
Finance | 3 |
Health Technology | 3 |
Electronic Technology | 2 |
Consumer Non-Durables | 2 |
Operativa
Director/Board Member | 6 |
Independent Dir/Board Member | 5 |
Chief Executive Officer | 5 |
Comptroller/Controller/Auditor | 4 |
Undergraduate Degree | 4 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Tae-Goo Kim
- Conexiones Empresas